» Articles » PMID: 22583132

Reduction of Insulin Signalling Pathway IRS-1/IRS-2/AKT/mTOR and Decrease of Epithelial Cell Proliferation in the Prostate of Glucocorticoid-treated Rats

Overview
Publisher Wiley
Specialty Pathology
Date 2012 May 16
PMID 22583132
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies by our research group using a model of insulin resistance induced by dexamethasone (DEX) showed that in the rat ventral prostate there was epithelial and smooth muscle cell atrophy and there were also alterations in fibroblasts. Proteins of the insulin signalling pathway are known to be very important for cell proliferation and development. Thus, we investigated the insulin signalling pathway and epithelial proliferation in the rat ventral prostate in this model and correlated the findings with expression of glucocorticoid (GR) and androgen (AR) receptors. Insulin resistance was induced in adult male Wistar rats by injection of DEX (1 mg/kg, ip for 5 consecutive days), whereas control (CTL) rats received saline. DEX treatment resulted in a significant decrease in body weight, but not in prostate weight. Reductions in insulin receptor 1 (IRS-1) (CTL 1.11 ± 0.06; DEX 0.85 ± 0.03), IRS-2 (CTL 0.95 ± 0.05; DEX 0.49 ± 0.04), AKT (CTL 0.98 ± 0.03; DEX 0.78 ± 0.02), mammalian target of rapamycin (mTOR; CTL 0.65 ± 0.08; DEX 0.22 ± 0.05), GR (CTL 1.30 ± 0.09; DEX 0.57 ± 0.10) and AR (CTL 1.83 ± 0.16; DEX 0.55 ± 0.08) protein levels were observed in the prostate of DEX-treated rats. The expression of the IRα-subunit, phosphoinositide 3-kinase, p-AKT, p70(S6K) , extracellular signal-regulated kinase (ERK) and p-ERK was not altered. The frequency of AR-positive cells in the epithelium of the prostate decreased in the glucocorticoid-treated group, and the intensity of the reaction for this receptor in the cell nuclei was lower in this group. Furthermore, the treatment with DEX reduced the frequency of proliferating cell nuclear antigen-positive (PCNA) cells 30-fold. This study suggests that the reduction in the insulin signalling pathway proteins IRS-1/IRS-2/AKT/mTOR in the prostate of DEX-treated rats may be associated with the morphological alterations observed previously.

Citing Articles

Dysregulated mTOR networks in experimental sporadic Alzheimer's disease.

de la Monte S, Tong M Front Cell Neurosci. 2024; 18:1432359.

PMID: 39386180 PMC: 11461251. DOI: 10.3389/fncel.2024.1432359.


3,3',4,5'-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress.

Tan Y, Miao L, Xiao J, Cheang W Curr Issues Mol Biol. 2022; 44(5):2175-2185.

PMID: 35678676 PMC: 9164067. DOI: 10.3390/cimb44050147.


(-)-Leucophyllone, a Tirucallane Triterpenoid from Enhances Insulin Secretion in INS-1 Cells.

Lee D, Kim K, Jang T, Kang K Plants (Basel). 2021; 10(3).

PMID: 33668330 PMC: 7996230. DOI: 10.3390/plants10030431.


AAV delivery of shRNA against IRS1 in GABAergic neurons in rat hippocampus impairs spatial memory in females and male rats.

Sanchez-Sarasua S, Ribes-Navarro A, Beltran-Bretones M, Sanchez-Perez A Brain Struct Funct. 2020; 226(1):163-178.

PMID: 33245394 DOI: 10.1007/s00429-020-02155-x.


White sweet potato ameliorates hyperglycemia and regenerates pancreatic islets in diabetic mice.

Shih C, Chen C, Varga V, Shih L, Chen P, Lo S Food Nutr Res. 2020; 64.

PMID: 32425738 PMC: 7217293. DOI: 10.29219/fnr.v64.3609.


References
1.
JACKSON F, HUTSON J . Altered responses to androgen in diabetic male rats. Diabetes. 1984; 33(9):819-24. DOI: 10.2337/diab.33.9.819. View

2.
Nishimura K, Nonomura N, Satoh E, Harada Y, Nakayama M, Tokizane T . Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst. 2001; 93(22):1739-46. DOI: 10.1093/jnci/93.22.1739. View

3.
Chen R, Kim O, Yang J, Sato K, Eisenmann K, McCarthy J . Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem. 2001; 276(34):31858-62. DOI: 10.1074/jbc.C100271200. View

4.
Kaarbo M, Mikkelsen O, Malerod L, Qu S, Lobert V, Akgul G . PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. Cell Oncol. 2010; 32(1-2):11-27. PMC: 4619056. DOI: 10.3233/CLO-2009-0487. View

5.
Cheatham B, Kahn C . Insulin action and the insulin signaling network. Endocr Rev. 1995; 16(2):117-42. DOI: 10.1210/edrv-16-2-117. View